title: Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
abstract: A new kind of versatile adenoviral vector (AdV) has been constructed, one that is completely replication disabled in the absence of Ad-E1 proteins but is capable of a single round of replication when Ad-E1 is present. This was made possible by deletion of the Ad protease gene (PS), which is essential for many steps of the Ad life cycle. The PS-deleted virus can be propagated in 293-derived cell lines engineered to express PS. In these new complementing cells, the PS gene was expressed from a tetracycline-inducible promoter in a dicistronic vector coexpressing the green fluorescent protein (GFP). When induced, the best 293-PS stable clones produced the PS in amounts greater than the level reached after Ad infection. Biological activity was first demonstrated by the ability of 293-PS cells to support the replication of Ad2ts1, a mutant expressing a functionally defective PS. While overexpression of the Ad PS slightly affected cell growth, moderate expression at levels sufficient to fully complement Ad2ts1 was well tolerated in 293 cells. Two PS-deleted mutants, deleted or not deleted for E1/E3, were then generated and characterized. Despite their complete loss of infectivity after a single round of replication in permissive cells, the PS-deleted mutants produced as much viral protein as wildtype Ad. These new vectors should thus be both safer and more efficient for applications in which enhancement of transgene expression is desirable, as in the case of vaccination, in situ therapy for tumors, protein production, or the large-scale production of other viral vectors such as adeno-associated virus (AAV).
authors.affiliation: Institut de Recherche en Biotechnologie, Conseil National de Recherche Canada, Montréal, QC.
authors.forename: W
authors.initials: W
authors.lastname: Oualikene
authors.forename: L
authors.initials: L
authors.lastname: Lamoureux
authors.forename: J M
authors.initials: JM
authors.lastname: Weber
authors.forename: B
authors.initials: B
authors.lastname: Massie
mesh_terms: D017498:Adenovirus E1 Proteins / Q000235:genetics*; D017503:Adenovirus E3 Proteins / Q000235:genetics; D000260:Adenoviruses, Human / Q000235:genetics* / Q000378:metabolism; D002460:Cell Line; D003673:Defective Viruses / Q000235:genetics* / Q000378:metabolism; D004926:Escherichia coli / Q000235:genetics; D017353:Gene Deletion; D005786:Gene Expression Regulation; D015967:Gene Expression Regulation, Viral; D005816:Genetic Complementation Test; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics*; D049452:Green Fluorescent Proteins; D006801:Humans; D008164:Luminescent Proteins / Q000235:genetics; D010447:Peptide Hydrolases / Q000235:genetics / Q000378:metabolism; D010957:Plasmids; D011995:Recombination, Genetic; D014162:Transfection; D014407:Tumor Cells, Cultured; D014779:Virus Replication
chemical_list: D017498:Adenovirus E1 Proteins; D017503:Adenovirus E3 Proteins; D008164:Luminescent Proteins; D049452:Green Fluorescent Proteins; D010447:Peptide Hydrolases